U.S. Online Retail and Ecommerce Stock News

ON Semiconductor (NasdaqGS:ON) approved a new share repurchase program of up to US$6b. The company completed its prior capital return program before authorizing the new buyback. Management highlighted progress in AI data center related revenues and operational improvements aligned with long term margin goals. ON Semiconductor focuses on power and analog semiconductors used in areas such as industrial applications, automotive systems and computing. The new US$6b buyback and the update on AI...

GE HealthCare Technologies (NasdaqGS:GEHC) has introduced ReadyFix, a remote fleet management solution for healthcare systems. The company has also received FDA 510(k) clearance and CE Marking for Allia Moveo, an imaging system for interventional suites. Both product milestones expand the company’s presence in digital health and interventional imaging. For you as an investor, these launches sit in the core of GE HealthCare’s business in medical imaging, digital tools and service support for...

If you are wondering whether NCR Voyix is priced attractively or not, this article will walk through what the current share price might be implying about value. The stock last closed at US$9.81, after a 7.0% gain over the past week, although returns over 30 days, year to date and the last year sit at 11.1%, 0.5% and 22.0% declines respectively. Recent attention on NCR Voyix has focused on how the business is reshaping itself around software and services for payments and retail technology,...

If you are wondering whether Aramark at around US$38.80 is offering fair value or hiding a margin of safety, you are asking the right question before making any long term decisions. The share price sits near US$38.80, with returns of 1.9% over 7 days, 6.1% year to date and 4.5% over 1 year. The 3 year and 5 year returns of 42.6% and 53.8% hint at a stock that has already moved a fair distance. Recent news around Aramark has largely focused on its role as a major provider of food, facilities...

In recent weeks, Blackstone has reported full-year 2025 results showing higher revenue and net income year-on-year, raised its quarterly dividend to US$1.49 per share, continued share repurchases, and joined Coatue Capital in extending a US$10 billion private credit facility to Australian data center company Firmus Technologies. Together, these moves highlight how Blackstone is pairing large-scale private credit exposure to AI-linked infrastructure with ongoing cash returns to shareholders...

Event context and recent share performance WillScot Holdings (WSC) has seen mixed share performance recently, with a 7 day return of 8.2%, a small decline over the past month, and a 20.6% gain over the past 3 months. See our latest analysis for WillScot Holdings. At a share price of US$21.64, WillScot Holdings has recently shown short term momentum with a 7 day share price return of 8.2%. However, the 1 year total shareholder return of 42.0% decline and 3 year total shareholder return of...

T-Mobile US and Amdocs have extended their partnership for multiple years to support expansion and AI-driven projects. The agreement includes work on generative AI and new integration projects for T-Mobile US consumer and business offerings. The move is intended to support operational efficiency and AI powered services across T-Mobile US platforms. T-Mobile US, NasdaqGS:TMUS, is trading at $197.66, with the share price sitting below its 1 year level and above its 3 year and 5 year levels...

What the latest earnings tell you about Freedom Holding Freedom Holding (FRHC) just released results for the third quarter and nine months to December 31, 2025, with both revenue and net income lower than the same periods a year earlier. For the quarter, revenue came in at US$628.62 million versus US$664.58 million a year ago, while net income was US$76.24 million compared with US$78.28 million. Basic earnings per share from continuing operations were US$1.27, with diluted EPS at US$1.25,...

Kirby (KEX) is back in focus after reporting fourth quarter revenue of US$851.78 million and net income of US$91.81 million, alongside an update on its long running share repurchase program. See our latest analysis for Kirby. The latest earnings and ongoing buybacks come after a strong 90 day share price return of 8.98% and a 1 year total shareholder return of 11.90%, with 3 and 5 year total shareholder returns of 64.86% and 97.51%. This suggests longer term momentum has been stronger than...

Lennox International (NYSE:LII) has completed a new share repurchase tranche, buying back nearly 0.85% of its shares in the most recent quarter. This brings total buybacks under the long running program to almost 40% of the company’s outstanding shares. The latest activity reflects an ongoing focus on returning capital to shareholders through repurchases. For investors watching NYSE:LII, the scale of the buyback program is now a core part of the story. The stock closed at $529.29, with...

If you are wondering whether Progyny's current share price reflects its true worth, this article walks through what the numbers are really saying about the stock. After closing at US$21.65, the shares have seen recent pressure, with returns of a 10.6% decline over 7 days, 19.8% decline over 30 days, 15.9% decline year to date, 3.1% decline over 1 year, 32.9% decline over 3 years, and 57.0% decline over 5 years. These moves come against a backdrop of ongoing interest in fertility benefits and...

In the past year, Liberty Broadband reported a net loss of US$2,676 million for 2025, compared with net income of US$869 million in 2024, while also completing a long-running share repurchase totaling 58,804,650 shares for US$8,115.32 million under its 2016 authorization. This sharp swing from profit to loss, alongside the conclusion of a very large multi-year buyback, raises important questions about how Liberty Broadband balances capital returns with earnings quality. With recent share...

Kaspi.kz context and recent share performance Kaspi.kz (KSPI) has been drawing investor attention after recent trading, with the stock last closing at US$76.36 and showing mixed returns over the past month and past 3 months. See our latest analysis for Kaspi.kz. That recent 3.48% 1 day share price gain comes after a softer patch, with a 30 day share price return of 6.7% decline and a 1 year total shareholder return of 21.15% decline. This suggests momentum has cooled after earlier multi year...

Summit Therapeutics Inc. previously announced that the FDA accepted for filing its Biologics License Application for ivonescimab plus chemotherapy in EGFR‑mutated, locally advanced or metastatic non-squamous NSCLC after tyrosine kinase inhibitor therapy, assigning a PDUFA action date of November 14, 2026. Beyond this U.S. filing, Summit and partner Akeso have broadened ivonescimab’s late-stage program across multiple Phase III trials and tumor types, underscoring a concerted push to position...

XPeng has launched smart charging payment services in Hong Kong through a global partnership with Antom. The rollout introduces a unified system that supports multiple local payment methods for EV charging. The service is designed to simplify cross border charging payments for XPeng drivers and other EV users. XPeng (NYSE:XPEV), trading at around $17.54, is adding this smart charging payment launch to a period of mixed share performance, with the stock up 6.4% over the past week but lower...

Mettler-Toledo International (NYSE:MTD) reported strong Q4 results, with broad-based growth across regions and product lines. The company reached US$1b in annual service revenue for the first time, marking a key milestone in its service business. Management highlighted continued progress in automation and digitalization initiatives, alongside expansion in emerging markets and high-growth segments. Results came despite ongoing headwinds from tariffs and currency movements. Mettler-Toledo...

Biogen (NasdaqGS:BIIB) reports strong commercial performance for Alzheimer’s treatment Leqembi, reflected in collaboration revenues and in market sales. The US FDA grants Breakthrough Therapy Designation to litifilimab for cutaneous lupus erythematosus, marking a key step in Biogen’s immunology efforts. Biogen announces promising clinical results for a high dose SPINRAZA regimen for spinal muscular atrophy, with regulatory review ongoing in the US and approvals already in the EU and...

MGM Resorts International recently reported fourth-quarter 2025 results showing higher sales of US$3,433.3 million and revenue of US$4,605.27 million, alongside completing two share repurchase programs totaling US$2,389.19 million and recording a US$22.79 million goodwill impairment. Management highlighted record profitability in Macau, a sharp improvement at BetMGM, and the easing of renovation-related disruption in Las Vegas as key operational themes. With these updates and management’s...

If you are looking at Kinetik Holdings and wondering whether the recent price is fair, rich, or leaves some room on the table, you are in the right place for a clear look at value. The stock closed at US$42.25, with returns of 5.3% over the last 7 days, 15.1% over the last 30 days, 15.9% year to date, and a 28.4% decline over the past year, while the 3 year return sits at 80.7%. These moves are sitting against a backdrop of ongoing interest in US energy infrastructure and midstream names,...

If you are wondering whether AppLovin is still worth a spot on your watchlist at current prices, this article focuses squarely on what the numbers say about its value. The share price closed at US$460.38, with a 7 day return of 4.7% decline, a 30 day return of 28.9% decline and a year to date return of 25.5% decline, while the 1 year return is 19.8% and the 3 year return is a very large gain. Recent news around AppLovin has focused on its role in mobile app marketing and software, which has...

Apollo Global Management (NYSE:APO) has entered a partnership with Schroders to create hybrid investment products for wealth and retirement clients. The collaboration brings together public and private market expertise to address demand for more diversified portfolios. Initial products are expected to launch in the UK and US, with the partners targeting multi billion dollar flows per year. Apollo Global Management, trading at $133.95, is expanding further into the wealth and retirement...

If you are wondering whether Omega Healthcare Investors is still fairly priced after its recent run, you are not alone. This article focuses squarely on what you are getting for the current share price. With the stock at US$44.79 and returns of 4.1% over 7 days, 1.2% over 30 days, 0.6% year to date, 29.8% over 1 year, 97.0% over 3 years and 78.7% over 5 years, many investors are now asking whether the current price reflects its fundamentals or already incorporates higher expectations and...

If you are wondering whether Kraft Heinz is a value opportunity or a value trap, its recent share performance and current pricing give you a lot to think about. The stock last closed at US$24.58, with returns of 4.6% over 7 days and 5.0% over 30 days, while the 1 year return sits at a 10.0% decline and the 3 year return at a 29.2% decline. Recent attention on Kraft Heinz has focused on how investors view its brand portfolio and cost structure, especially as packaged food companies face...

Why BKV’s latest power moves matter for investors BKV (BKV) has moved quickly to complete its Power WI acquisition and lift its stake in a power joint venture to 75%, giving it majority control of the Temple I and Temple II plants in Texas. These steps increase BKV’s exposure to power generation alongside its natural gas operations, and have already prompted fresh analyst modeling ahead of the company’s fourth quarter 2025 earnings update. See our latest analysis for BKV. At a share price of...